Skip to main content
SpringerLink
Log in

Breast Cancer

Advances in Management

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Beadle GT, et al. Cosmetic results following primary radiation therapy for early breast cancer. Cancer 54: 2911, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, Valagussa P. Dose response effect of adjuvant chemotherapy in breast cancer. New England Journal of Medicine 304(1): 10–15, 1981

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, Valagussa P. Current status of adjuvant chemotherapy for breast cancer. Seminars in Oncology 14(1): 8, 1986

    Google Scholar 

  • Bonadonna G, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. New England Journal of Medicine 294: 405, 1976

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, et al. Adjuvant chemotherapy in breast cancer. Lancet 1: 1157, 1983

    Article  PubMed  CAS  Google Scholar 

  • Clark GM, et al. Progesterone receptors as a prognostic factor in stage II breast cancer. New England Journal of Medicine 309: 1343, 1983

    Article  PubMed  CAS  Google Scholar 

  • Consensus Conference. Adjuvant chemotherapy for breast cancer. Journal of the American Medical Association 254: 3461, 1985

    Google Scholar 

  • Danoff B, Goodman RL. Identification of a subgroup of patients with breast cancer in whom conservative surgery and radiation is contraindicated. Abstract. International Journal of Radiation: Oncology — Biology — Physics II(Suppl. 1): 104, 1985

    Google Scholar 

  • Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine 312: 137, 1985

    Article  Google Scholar 

  • Editorial. Treatment of cancer: review of mortality results in randomised trial in early breast cancer. Lancet 2: 1205, 1984

  • Findlay P, et al. A randomised trial comparing mastectomy to radiotherapy in the treatment of stage I-II breast cancer: a preliminary report. Proceedings of the American Society of Clinical Oncology 4: C–230, 1985

    Google Scholar 

  • Fisher B, Wolmark N. Conservative surgery: the American experience. Seminars in Oncology 13: 425, 1986

    PubMed  CAS  Google Scholar 

  • Fisher B, et al. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. New England Journal of Medicine 292: 117, 1975

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4) VI. Discriminants for 5 year treatment failure. Cancer 46: 908, 1980

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 52: 1551, 1983

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New England Journal of Medicine 312: 665, 1985

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, et al. Prolonging tamoxifen therapy for primary breast cancer. Annals of Internal Medicine 106: 649, 1987

    PubMed  CAS  Google Scholar 

  • Haller DG, Glick JH. Progestational agents in advanced breast cancer: an overview. Seminars in Oncology 13(4): 2, 1986

    PubMed  CAS  Google Scholar 

  • Harris JR, et al. Cancer of the breast. In DeVita VT, et al. (Eds) Cancer, principles and practice of oncology, 2nd ed. p. 1119–1177, JB Lippincott, Philadelphia, 1985

    Google Scholar 

  • Henderson IC, et al. New agents and new medical treatments for advanced breast cancer. Seminars in Oncology 14(1): 34, 1987

    PubMed  CAS  Google Scholar 

  • Kennedy BJ. Hormonal therapies in breast cancer. Seminars in Oncology 1: 119, 1974

    PubMed  CAS  Google Scholar 

  • Kiang DT, Kennedy BJ. Factors affecting oestrogen receptors in breast cancer. Cancer 40: 1571, 1977

    Article  PubMed  CAS  Google Scholar 

  • Land CE. Low dose irradiation — a cause of breast cancer? Cancer 46: 868, 1980

    Article  PubMed  CAS  Google Scholar 

  • Leathem AJ, Brooks SA. Predictive value of lectin binding on breast cancer recurrence and survival. Lancet 1: 1054, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ludwig Breast Cancer Study Group. Randomized trial of chemoendocrine therapy, endocrine therapy and mastectomy alone in post menopausal patients with operable breast cancer and axillary node metastasis. Lancet 1: 1256, 1984

    Google Scholar 

  • Mant D, et al. Breast self examination and breast cancer stage at diagnosis. British Journal of Cancer 55: 207, 1987

    Article  PubMed  CAS  Google Scholar 

  • McDivitt RW, et al. A proposed classification of breast cancer based on kinetic information. Cancer 57: 269, 1986

    Article  PubMed  CAS  Google Scholar 

  • Miller AB, Bulbrook RD. The epidemiology and etiology of breast cancer. New England Journal of Medicine 303: 1246, 1980

    Article  PubMed  CAS  Google Scholar 

  • Musey VC, et al. Long-term effect of a first pregnancy on the secretion of prolactin. New England Journal of Medicine 316: 229, 1987

    Article  PubMed  CAS  Google Scholar 

  • Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1: 836, 1985

    Google Scholar 

  • O’Connell DL, et al. Cigarette smoking, alcohol consumption, and breast cancer risk. Journal of the National Cancer Institute 72(2): 229, 1987

    Google Scholar 

  • Ottman R, et al. Practical guide for estimating risk for familial breast cancer. Lancet 2: 556, 1983

    Article  PubMed  CAS  Google Scholar 

  • Plotkin D, et al. Tamoxifen flare in advanced breast cancer. Journal of the American Medical Association 240: 2644, 1978

    Article  PubMed  CAS  Google Scholar 

  • Recht A, et al. Conservative surgery and radiation therapy for early breast cancer: results, controversies and unsolved problems. Seminars in Oncology 13(4): 434, 1986

    PubMed  CAS  Google Scholar 

  • Rosner D, et al. A randomised study of intensive versus moderate chemotherapy programs in metastatic breast cancer. Cancer 59: 874, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sarrazin D, et al. Conservative treatment versus mastectomy in breast cancer tumours with macroscopic diameter of 20 millimeters or less: the experience of the Institut Gustav Roussy. Cancer 53: 1209, 1984

    Article  PubMed  CAS  Google Scholar 

  • Sattin RW, et al. Oral-contraceptive use and the risk of breast cancer: the cancer and steroid hormone study of the Centers for Disease control and the National Institute of Child Health and Human Development. New England Journal of Medicine 315: 405, 1986

    Article  Google Scholar 

  • Schatzkin A, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the First National Health and Nutrition Examination Survey. New England Journal of Medicine 316: 1169, 1987

    Article  PubMed  CAS  Google Scholar 

  • Shapiro S, et al. Ten to fourteen year effects of breast cancer screening on mortality. Journal of the National Cancer Institute 69: 349, 1982

    PubMed  CAS  Google Scholar 

  • Stuart-Harris R, et al. Low-dose aminoglutethimide in treatment of advanced breast cancer. Lancet 2: 604, 1984

    Article  PubMed  CAS  Google Scholar 

  • Sutherland DCM, Mather FJ. Long term survival and prognostic factors in patients with regional breast cancer. Cancer 55: 1389, 1985

    Article  PubMed  CAS  Google Scholar 

  • Tabar L, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1: 829, 1985

    Article  PubMed  CAS  Google Scholar 

  • Tormey DC. Long term adjuvant therapy with tamoxifen in breast cancer: how long is long? Annals of Internal Medicine 106: 762, 1987

    PubMed  CAS  Google Scholar 

  • Valagussa P, et al. T3b-T4 breast cancers: factors affecting results in combined modality treatments. Clinical Experimental Metastasis I: 191, 1983

    Article  Google Scholar 

  • Van Heerden JA, et al. Surgical technique and pitfalls of breast reconstruction immediately after mastectomy for carcinoma: initial experience. Mayo Clinic Proceedings 62: 185, 1987

    PubMed  Google Scholar 

  • Veronesi U, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. New England Journal of Medicine 305: 6, 1981

    Article  PubMed  CAS  Google Scholar 

  • Willett WC, et al. Dietary fat and the risk of breast cancer. New England Journal of Medicine 316: 22, 1987a

    Article  PubMed  CAS  Google Scholar 

  • Willett WC, et al. Moderate alcohol consumption and the risk of breast cancer. New England Journal of Medicine 316: 1174, 1987b

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Prince Henry’s Hospital, St Kilda Road, Melbourne, Victoria, 3004, Australia

    Graeme N. Brodie (Director of Medical Oncology) & Andrew Elefanty

Authors
  1. Graeme N. Brodie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Elefanty
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodie, G.N., Elefanty, A. Breast Cancer. Drugs 35, 584–595 (1988). https://doi.org/10.2165/00003495-198835050-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198835050-00006

Keywords

Search

Navigation